Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Express Scripts
Accenture
Julphar
Healthtrust
AstraZeneca
Cerilliant
Deloitte
Covington
Federal Trade Commission

Generated: January 17, 2018

DrugPatentWatch Database Preview

Venlafaxine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for venlafaxine hydrochloride and what is the scope of venlafaxine hydrochloride freedom to operate?

Venlafaxine hydrochloride
is the generic ingredient in three branded drugs marketed by Wyeth Pharms Inc, Anchen Pharms, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Macleods Pharms Ltd, Mylan, Orchid Hlthcare, Teva, Torrent Pharms Llc, Valeant Pharms North, Wockhardt, Zydus Pharms Usa Inc, Nostrum Labs Inc, Osmotica Pharm, Sun Pharma Global, Alembic Pharms Ltd, Amneal Pharms, Aurobindo Pharma, Heritage Pharms Inc, Pliva Hrvatska Doo, Prinston Inc, Sandoz, Sun Pharm Inds Inc, Yaopharma Co Ltd, and Zydus Pharms Usa, and is included in twenty-nine NDAs. There are five patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Venlafaxine hydrochloride has ninety-two patent family members in forty-four countries.

There are seventy-one drug master file entries for venlafaxine hydrochloride. Seventy-seven suppliers are listed for this compound. There are two tentative approvals for this compound.
Summary for venlafaxine hydrochloride
Pharmacology for venlafaxine hydrochloride
Medical Subject Heading (MeSH) Categories for venlafaxine hydrochloride
Tentative approvals for VENLAFAXINE HYDROCHLORIDE
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe37.5MGCAPSULE, EXTENDED RELEASE; ORAL
➤ Subscribe➤ Subscribe150MGCAPSULE, EXTENDED RELEASE; ORAL
➤ Subscribe➤ Subscribe75MGCAPSULE, EXTENDED RELEASE; ORAL

US Patents and Regulatory Information for venlafaxine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Amneal Pharms VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 079098-002 May 11, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Osmotica Pharm VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-001 May 20, 2008 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Osmotica Pharm VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-002 May 20, 2008 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharm Inds Inc VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 078627-004 Jun 13, 2008 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Amneal Pharms VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 079098-003 May 11, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Anchen Pharms VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 078087-003 Mar 16, 2012 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET;ORAL 076690-005 Aug 3, 2006 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Osmotica Pharm VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-004 May 20, 2008 AB RX Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc EFFEXOR venlafaxine hydrochloride TABLET;ORAL 020151-005 Dec 28, 1993 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sun Pharma Global VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 091272-001 Aug 18, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for venlafaxine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms Inc EFFEXOR XR venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020699-001 Oct 20, 1997 ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc EFFEXOR XR venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020699-001 Oct 20, 1997 ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc EFFEXOR XR venlafaxine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020699-002 Oct 20, 1997 ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc EFFEXOR venlafaxine hydrochloride TABLET;ORAL 020151-001 Dec 28, 1993 ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc EFFEXOR venlafaxine hydrochloride TABLET;ORAL 020151-006 Dec 28, 1993 ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc EFFEXOR venlafaxine hydrochloride TABLET;ORAL 020151-004 Dec 28, 1993 ➤ Subscribe ➤ Subscribe
Osmotica Pharm VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-001 May 20, 2008 ➤ Subscribe ➤ Subscribe
Osmotica Pharm VENLAFAXINE HYDROCHLORIDE venlafaxine hydrochloride TABLET, EXTENDED RELEASE;ORAL 022104-004 May 20, 2008 ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc EFFEXOR venlafaxine hydrochloride TABLET;ORAL 020151-006 Dec 28, 1993 ➤ Subscribe ➤ Subscribe
Wyeth Pharms Inc EFFEXOR venlafaxine hydrochloride TABLET;ORAL 020151-002 Dec 28, 1993 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for venlafaxine hydrochloride

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Deloitte
Colorcon
Boehringer Ingelheim
Johnson and Johnson
US Department of Justice
Argus Health
Cantor Fitzgerald
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot